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Abstract
An assembled suite of flow-based transformations have been used to rapidly scale-up the production of a novel auxin mimic-based
herbicide which was required for preliminary field trials. The overall synthetic approach and optimisation studies are described
along with a full description of the final reactor configurations employed for the synthesis as well as the downstream processing of
the reaction streams.
Introduction
Indoles are amongst the most important bioactive heterocyclic
structures being commonly encountered in the amino acid tryp-
tophan (1), the related neurotransmitter serotonin (2) as well as
numerous complex alkaloid natural products and pharmaceuti-
cals [1-4]. Indoles also play a significant role as phytohor-
mones that promote and regulate the growth and development
of plants. Indeed, four of the five endogenously synthesised
auxins produced by plants contain the indole motif (Figure 1,
structures 3–7). As a consequence of their regulatory activity
these structures have become prime targets for investigations
into both enhancing plant growth as well as targeted plant
growth inhibition generating new agrochemical herbicides [5].
A recent collaboration investigating the uptake and resulting
distribution of synthetic indole-3-acetic acid analogues in broad
leaf plant species (dicotyledons) required the preparation of
structure 8 (Figure 1) at scale for extended field trials. Further-
more as weather patterns and environmental concerns impact
significantly on the timing and ultimately the quantities of ma-
terial required in such studies it was also deemed highly desir-
able to be able to produce material on demand using a flexible
scale flow chemistry approach.
Since the report of the first synthetic access to indoles by
Fischer in 1835 more than a dozen further unique indole synthe-
ses have been reported showcasing the importance of devel-
oping new entries into these valuable structures [6]. However,
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Figure 1: Natural indole containing molecules 1–7 of biological importance and synthetic auxin analogue 8 required at scale and X-ray structure.
Scheme 1: Synthetic strategy towards desired indole product 8.
common to the majority of these indole syntheses is the use of
hazardous entities such as hydrazines (Fischer), diazonium
species (Japp–Klingemann) or azides (Hemetsberger–Knittel)
or the necessity to construct specifically functionalised precur-
sors in a multistep sequence prior to indole ring formation [7].
In order to address these potential shortcomings we set out to
develop a benign process relying on inexpensive substrates and
non-toxic reagents that would rapidly deliver the desired indole
in a readily scalable and continuous fashion.
Results and Discussion
In order to generate the core indole unit through a robust syn-
thetic sequence we decided to investigate the treatment of a
2-chloronitrobenzene 9 with ethyl cyanoacetate (10) as the
nucleophile in a base-mediated SNAr reaction (Scheme 1). The
resulting adduct 11 would then be subjected to heterogeneous
hydrogenation conditions to produce the indole product 12
through a reductive cyclisation sequence. From the correspond-
ing ester functionalised indole 12 we anticipated that condensa-
tion with hydrazine would furnish the corresponding acyl
hydrazine 13 which could be cyclised to the desired product 8
through the action of a reactive carbonyl donor such as CDI
(1,1′-carbonyldiimidazole) or triphosgene (bis(trichloro-
methyl)carbonate). This synthetic strategy presented various
advantages as it relies on readily available substrates and
reagents, creates small amounts of non-toxic byproducts
Beilstein J. Org. Chem. 2017, 13, 2549–2560.
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Table 1: Optimisation experiments for SNAr with ethyl cyanoacetate (10).a
Entry 9 [M] 10 (equiv) Solventb Basec (equiv) Temp. (°C) % Conv.
1 0.25 2 MeCN Et3N (5) 50 8
2 0.25 2 DCM Et3N (5) 40 3
3 0.25 2 DMF Et3N (5) 70 6
4 0.5 2 DMF TMG (3) 40 98
5 0.75 2 DMF TMG (3) 40 100d
6 0.25 1 DMF TMG (3) 40 88
7 0.25 2 DCM TMG (3) 40 100
8 0.25 2 EtOH NaOEt (3) 40 –e
9 0.25 2 t-BuOH KOt-Bu 40 44d
10 0.25 2 DMF K2CO3 (5) 40 100d
11 0.25 2 THF TMG (3) 50 55d
12 0.25 2 EtOAc TMG (3) 50 90d
13 0.25 2 EtOAc/MeCN 5:1 TMG (2.5) 50 >98
14 0.25 2 EtOH TMG (3) 50 64
15 0.25 2 MeCN TMG (3) 50 100
16 0.25 1 MeCN TMG (3) 50 90
17 0.25 1.5 MeCN TMG (3) 50 100
18 0.25 1.2 MeCN TMG (3) 50 100
19 0.25 1.1 MeCN TMG (3) 50 100
20 0.25 1.1 MeCN TMG (2) 50 87
21 0.25 1.1 MeCN TMG (2.2) 50 94
22 0.25 1.1 MeCN TMG (2.5) 50 100
23 0.25 1.1 MeCN TMG (2.5) 40 96
24 0.25 1.1 DCM TMG (2.5) 50 100
25 0.25 1.1 DCM TMG (2.5) 40 89
26 0.5 1.1 DMF TMG (2.5) 50 100
27 0.25 2 EtOAc/MeCN 5:1 TMG (2.5) 50 100
aAll reactions were run in Biotage microwave vials being irradiated at the specified temperature for 1 hour. The organic phase was analysed after
work-up by quenching with 1 M HCl (and extraction with EtOAc if required), drying over anhydrous Na2SO4 and solvent evaporation. Conversion to
product was based upon calibrated LC. bSolvents were tested for full solubility of reagents and for the deprotonated ethyl cyanoacetate (10) prior to
full testing. cIt was determined that DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) and TMG (1,1,3,3-tetramethylguanidine) could be used interchange-
ably without any effect on the yield or product purity, for clarity only the results with TMG are shown. dSolid formation occurred during the reaction.
eComplex mixture generated including direct addition of the ethoxide anion.
(base·HCl, H2O) and uses industrially favourable hydrogena-
tion protocols in the key cyclisation step.
To commence the study we first conducted a comprehensive
screening program to determine flow compatible conditions for
the formation of compound 11 optimising for solvent, base,
temperature and reagent stoichiometry – selected results are
presented in Table 1.
Although DMF and MeCN were shown to be excellent solvents
for the reaction (Table 1, entries 3–6, 10, 15–23, and 26) we en-
countered difficulties in efficiently extracting the product upon
quenching the reactions (1 M HCl). EtOAc was promising and
made extraction very easy but during the reactions small quanti-
ties of a dark red, sticky, precipitate were observed (Table 1,
entry 12). This was considered problematic for processing in a
meso flow reactor due to the potential for causing blockages. It
was however found that the addition of between 10–20% v/v
MeCN ensure a fully homogeneous solution and also allowed
for simple aqueous extraction with good recovery (>90%).
However, from the provisional results DCM stood out as the
most viable solvent (Table 1, entries 7, 24 and 25) and allowed
a 0.25 M solution of substrate 9 to be processed with TMG or
DBU (2.5 equiv) and ethyl cyanoacetate (10, 1.1 equiv) at 50 °C
in quantitative conversion.
Based upon these screening results we devised a simple flow
set-up where two stock solutions were united at a simple
T-mixing piece and subsequently directed into a heated flow
coil reactor maintained at 50 °C (Scheme 2). The intensely red
coloured solution (anion of the SNAr adduct) [8] which quickly
formed was quenched after the incubation period (35–108 min)
Beilstein J. Org. Chem. 2017, 13, 2549–2560.
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Scheme 2: Initial flow reactor setup for the synthesis of intermediate 11.
using a third flow stream of hydrochloric acid (1 M) blended
via a dedicated mixer chip before the combined mixture was
phase separated.
To enable the phase separation we utilised a passive membrane
system based upon a modified Biotage universal separator [9].
This enabled the heavier chlorinated phase to be removed from
the lower connection and for the lighter aqueous phase to be
decanted from an overflow positioned run-off. At flow rates of
0.5–1.2 mL/min emanating from the main reactor this unit per-
formed reliably giving excellent quenching and separation.
However, at higher flow rates issues were encountered with
incomplete partitioning (some emulsion formation) of the
biphasic mixture resulting in the loss of product containing ma-
terial to the aqueous run off. This was determined to be a result
of the high shear generated in the in-line mixing chip at the
higher flow rates and the need for longer settling times of the
heavily segmented flow. This issue could be overcome by
directing the aqueous run off from the first separator into a
second equivalent unit or by simply splitting the original
quenched flow over two parallel separators. Although func-
tional these approaches were not the optimum in design or utili-
sation of the separator components. We therefore also investi-
gated the replacement of the problematic mixing chip with
various configured T- and Y-connectors but this immediately
gave other issues due to incomplete quenching which resulted
in poor product recovery and associated contamination. A more
straightforward approach proved to be to introduce a flow strati-
fication zone prior to the separator which was achieved through
the expedient introduction of a section of wider bore tubing
(expanded from the reactor i.d. 1.6 mm → 4.0 mm × 20 cm)
[10]. This enabled reactor throughput flow rates of up to 2.0 mL
(for flow rates above 1.0 mL a second 52 mL flow coil was
added to the system) to be successfully quenched inline and
then successively handled by a single Biotage universal sepa-
rator. In all cases the output from the main reactor showed
quantitative conversion with only the product being isolated
following solvent evaporation. At a flow rate of 1.8 mL/min
from the reactor this gave a maximum throughput of 27 mmol/h
operating at steady state.
Despite the versatility of the reactor its productivity was lower
than we ideally wanted and unfortunately DCM proved to be an
incompatible solvent with the following hydrogenation step. Al-
though solvent swapping would have been possible we deter-
mined that when EtOAc was used as the solvent and diluted
with EtOH in the presence of acetic acid as an additive this
allowed for the successful reductive cyclisation to the indole.
As a result we investigated the scaled synthesis of intermediate
11 in EtOAc. Having had previous success with handling slur-
ries in flow using the Coflore, AM technology ACR device
[11], we decided to utilise this equipment in the synthesis to
overcome the issues encountered with solubility [12-14].
The starting materials were prepared as individual stock solu-
tions in EtOAc and mixed sequentially, first the base and the
ethyl cyanoacetate (10) being combined (note this was an exo-
thermic process) before meeting a solution of the aryl chloride 9
and entering the ACR which was agitated at 8 Hz (Scheme 3).
In an attempt to intensify the process and with the specific aim
of reducing the amount of solvent in order to maintain a viable
working concentration in the subsequent reduction step (after
dilution with EtOH) we undertook a series of concentration and
flow rate optimisations. It was ultimately found that at a
combined flow rate of 3 mL which equated to a residence time
of approximately 30 min and a reactor temperature of 65 °C we
were able to achieve a quantitative conversion of a 1.5 M solu-
Beilstein J. Org. Chem. 2017, 13, 2549–2560.
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Scheme 3: Coflore ACR setup for the synthesis of intermediate 11.
Scheme 4: Quenching and work-up of the reaction stream from the Coflore ACR for the synthesis intermediate 11.
tion of substrate 9. Under continuous operation the reactor
output was a dark red suspension comprising approx. 10% solid
by volume but was easily processed through the system even
over extended periods of time (>14 h). This set-up gave a theo-
retical working throughput of 0.108 mol/h. Next, to facilitate
the integrated quenching and work-up we added a static mixing
element [15] at the confluence point of an aqueous solution of
2 M HCl delivered at a flow rate of 6 mL/min (Scheme 4). Evi-
dence for effective quenching was immediately observed by the
transformation of the dark red reaction mixture to a pale yellow
biphasic solution which quickly phase separated upon collec-
tion. Confirmation of the successful quenching was obtained by
1H NMR and LC analysis of the organic phase which indicated
only the product 11 and trace amounts of ethyl cyanoacetate
(10). Finally, manual separation followed by drying over
Na2SO4 and solvent evaporation gave the desired product 11 in
94–96% yield, based upon 6 sampled aliquots of 20 min each
processing time.
Several laboratory approaches to the automation of batch sepa-
ration have been reported using machine vision systems [16,17],
and inline detection devices employing optics [18] or inductive
conductivity (impedance measurements) [19] to determine
phase partitions. However, due to specific project time limita-
tions we were constrained to use a more manual approach but
would certainly incorporate such a labour saving device into a
future development version. Our basic system used a simple
batch collection vessel with two HPLC pumps with appropri-
ately positioned inputs to remove independently the aqueous
and organic phases. Occasional manual intervention allowed
intermittent recalibration of the pumps to maintain working
volumes and create a suitable phase segment for removal.
Again, following evaporation of the solvent a high isolated
yield of the target molecule 11 was attained in 93–97%.
The collected solution generated following aqueous quenching
and separation contained 0.4 M product 11 which was further
Beilstein J. Org. Chem. 2017, 13, 2549–2560.
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Table 2: Selected optimisation experiments for reductive cyclisation to compound 12.a
Entry AcOH (mol %) Temp. (°C) Pressure (bar) Flow rate
(mL/min)
Product composition
ratio 11:12:14:15
1 0 50 0 0.4 0:100:0:0
2 0 50 0 0.8 0:62:29:9
3 0 50 0 1.0 10:30:40:20
4 0 50 5 0.8 0:86:11:3
5 0 50 10 0.8 0:95:5:0
6 0 50 15 0.8 0:99:1:0
7 0 50 15 1.2 0:77:18:5
8 0 40 5 0.8 4:43:19:34
9 0 60 5 0.8 0:83:12:5
10 0 70 5 0.8 3:46:23:9b
11 5 50 0 0.8 0:80:17:3
12 10 50 0 0.8 0:93:6:1
13 20 50 0 0.8 0:95:4:1
14 50 50 0 0.8 0:94:5:0
15 10 50 15 1.1 0:99:1:0
16 10 50 15 1.2 0:100:0:0
17 10 50 15 1.3 0:98:2:0
18 10 50 15 1.4 0:89:8:3
aReaction concentration of 11 was 0.2 M in EtOH/EtOAc 50:50 v/v. Composition analysis was performed by LC–MS against isolated standards. bAn
additional product of almost double the mass of 12 was observed in the LC–MS but this material could not be isolated. The catalyst cartridge rapidly
lost activity and could not be regenerated through washing.
diluted with EtOH to furnish a 0.2 M stock solution for use in
the next reductive cyclisation step. The reduction was per-
formed using a ThalesNano H-cube system [20,21] operating in
full hydrogen mode with a 10 mol % Pd/C catalyst cartridge. At
a flow rate of 0.4 mL/min and a temperature of 50 °C full
conversion to the indole product 12 was achieved (Table 2,
entry 1). When the flow rate was raised to 0.8–1 mL/min com-
plete consumption of the starting material was observed but a
mixture of products was isolated (Table 2, entries 2 and 3).
Careful analysis of the composition indicated the presence of
the desired product (12, 62%) along with two other compounds
(Figure 2), which following chromatographic isolation, were
assigned as the amino indole (14, 29%) and the N-hydroxy-
amino indole (15, 9%). As expected these latter two products
resulting from incomplete reduction were obtained in greater
amounts as the flow rate was further increased along with an in-
creasing proportion of the hydroxyaminoindole 15. This corre-
lates with previous literature findings employing catalysed
hydrogenation [22-26] or stoichiometric metal (zinc or indium)
mediated reduction and is consistent with a stepwise reduction
mechanism (Scheme 5) [27-29]. It is evident from the sequence
that several equivalents of hydrogen are necessary for full
reduction and as a result a higher concentration (pressure) of
hydrogen would be beneficial (Table 2, entries 4–10). We also
noted that according to the mechanism protonation of the
anilino nitrogen could be beneficial in promoting the reduction
steps as well as aiding in the loss of water (16 and 18) and
ammonia (20). We therefore screened a series of acid catalysts
which highlighted acetic acid (10–30 mol %) as the optimum
additive (Table 2, entries 11–14). Stronger acids or higher
loading of acid often resulted in the generation of high internal
pressures and in certain cases the formation of precipitates was
noted requiring premature termination of the run and a safe
shutdown. Using acetic acid and limiting the acid concentration
(10 mol %) whilst working at a higher internal pressure (15 bar)
enabled stable and continuous operation permitting the flow rate
to be raised to 1.3 mL/min whilst ensuring a >98% conversion
to the desired indole 12 (Table 2, entries 15–18) [30,31]. This
translated into a throughput of 15.6 mmol/h (3.7 g/h product).
The final product could be easily isolated in 93% yield as an off
white solid by solvent evaporation and trituration with 9:1
hexane/Et2O. This purification removed both residual acetic
acid and, if present, small traces of byproducts.
In the next sequence we looked at telescoping the final two
steps of the process; substitution of the ethoxy group by
hydrazine and then ring formation to the 3H-[1,3,4]oxadiazol-2-
one unit [32,33].
In this procedure a 0.95 M THF solution of compound 12 was
united with a solution of hydrazine (1.0 M in THF) and directed
into a heated flow coil to be superheated at 100 °C (Scheme 6).
Beilstein J. Org. Chem. 2017, 13, 2549–2560.
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Figure 2: X-ray structure of intermediate 11, and reductive cyclisation products 12 and 14, assigned structure of byproduct 15.
Scheme 5: Stepwise reduction of intermediate 11 under hydrogenation conditions. * Indicates potential tautomeric structure. Species in parentheses
are proposed transient intermediates.
A residence time of 40 min allowed full conversion to the corre-
sponding acyl hydrazine 13 which was directly intercepted with
a further input stream containing CDI (1.1 M in THF) and
heated at 75 °C for an additional 26 min in a second flow coil.
This furnished the final product 8 in quantitative conversion
with the product stream being readily purified by passage
Beilstein J. Org. Chem. 2017, 13, 2549–2560.
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Scheme 6: Flow sequence for the construction of product 8.
Scheme 7: Assembled process for flow synthesis of product 8 with yields and throughputs.
through a scavenging cartridge of QP-SA (a sulfonic acid func-
tionalised polymer). The product 8 was obtained after solvent
evaporation as a yellow solid (94%) but required recrystalliza-
tion from DCM to give a white amorphous powder of high
purity in 82% yield.
A series of attempts to employ dimethyl carbonate as a replace-
ment reagent for CDI in the final step failed under a range
of conditions as did trials to directly utilise (methoxy-
carbonyl)hydrazide (CAS 6294-89-9) in the previous acyl
hydrazine forming step. However, we found that triphosgene
(0.4 equiv) could be successfully used in the latter cyclisation
process [34-37]. Using a similar reactor assembly as per
Scheme 6 the triphosgene (0.8 M in CHCl3) was combined with
the solution of intermediate 13 and passed through a heated
(55 °C) flow coil and then through a packed bed scavenging
cartridge containing QP-DMA (N,N-dimethylbenzylamine poly-
styrene). Following solvent evaporation this gave the product as
an off white solid in 91% isolated yield. In practice this ap-
proach proved far superior to the previously employed CDI
cyclisation providing higher overall yields and improved quality
product direct from the reactor. Indeed, the final product 8 was
of sufficient purity for direct application allowing on demand
and scalable production from a stable intermediate 12 in less
than 2 h from reactor start-up.
Conclusion
Using the procedures outlined we have been able to rapidly
assembly the desired target molecule 8 through a flexible work-
flow generating sufficient material for on-going field trials.
Obviously in the context of our currently assembled route the
reductive cyclisation to the indole unit 12 is the process limiting
step (Scheme 7). However, several options including commer-
cially available larger scale flow apparatus for performing such
flow hydrogenations are available (i.e., H-Cube Mid [38],
FlowCAT [39]) [40,41]. However, as intermediate 12 was
shown to be a highly stable structure, in practice, this created a
convenient staging point to generate intermediate holding
Beilstein J. Org. Chem. 2017, 13, 2549–2560.
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batches of material for subsequent on demand processing.
Overall we envisage this laboratory scale design to offer several
opportunities for further development enabling quick up regula-
tion of production in the future.
Experimental
Material and methods
Unless otherwise stated, all solvents, substrates and reagents
were used as purchased without further purification.
1H NMR spectra were recorded on Bruker Avance-400 instru-
ments and are reported relative to residual solvent: CHCl3
(δ 7.26 ppm), DMSO (δ 2.50 ppm). 13C NMR spectra were re-
corded on the same instruments and are reported relative to
CHCl3 (δ 77.16 ppm) or DMSO (δ 39.52 ppm). Data for
1H NMR are reported as follows: chemical shift (δ ppm) (multi-
plicity, coupling constant (Hz), integration). Multiplicities are
reported as follows: s = singlet, d = doublet, t = triplet, q =
quartet, p = pentet, m = multiplet, br. s = broad singlet, app =
apparent. Data for 13C NMR are reported in terms of chemical
shift (δ ppm) and multiplicity (C, CH, CH2 or CH3). Data for
19F NMR were recorded on the above instruments at a frequen-
cy of 376 MHz using CFCl3 as external standard. For all com-
pounds DEPT-135, COSY, HSQC, and HMBC were run and
used in the structural assignment. IR spectra were recorded neat
(ATR sampling) with the intensities of the characteristic signals
being reported as weak (w, <20% of tallest signal), medium (m,
20–70% of tallest signal) or strong (s, >70% of tallest signal).
Low and high-resolution mass spectrometry was performed
using the indicated techniques on instruments equipped with
Acquity UPLC and a lock-mass electrospray ion source. For
accurate mass measurements the deviation from the calculated
formula is reported in ppm. Melting points were recorded on an
automated melting point system with a heating rate of 1 °C/min
and are uncorrected. Microwave optimisation reactions were
performed in a Biotage® Initiator+ microwave system.
Flow reactions were preformed using the pumping system of a
Vapourtec R-Series modular flow chemistry system [42].
Heating for the 52 mL flow coils was provided using a Polar
Bear Plus unit [43].
Ethyl 2-cyano-2-(2-nitro-4-(trifluoromethyl)phenyl)acetate
(11) [44]:
Process 1 (DCM): Two stock solutions in DCM were prepared.
Solution A: TMG (1.25 M, 2.5 equiv) and solution B: a mix-
ture of 4-chloro-3-nitrobenzotrifluoride (0.5 M, 1.0 equiv) and
ethyl cyanoacetate (0.55 M, 1.1 equiv). The two stock solutions
were pumped (0.65 mL/min each channel) direct from their
respective reservoirs to combine at a PEEK T-piece and were
then directed through a FEP flow coil (52 mL maintained at
50 °C using a Polar Bear Plus reactor – Cambridge Reactor
Design). The system pressure was controlled using a 75 psi
inline back pressure regulator. The flow stream was quenched
by mixing with a solution of hydrochloric acid (1 M) at a flow
rate of 2 mL/min within a glass microreactor (1 mL, Little
Things Factory). The biphasic mixture was passed into a section
of wide bore FEP tubing (4 mm i.d × 20 cm length) and on into
a modified Biotage Universal Separator (Biotage) allowing sep-
aration of the organic and aqueous fluidic flows. The organic
layer was dried (Na2SO4) and the solvent evaporated to yield
the title compound in 94–96%.
Process 2 (EtOAc): Three EtOAc stock solutions were pre-
pared. Solution A: DBU (3.75 M, 2.5 equiv), solution B: ethyl
cyanoacetate (1.65 M, 1.1 equiv), and solution C: 4-chloro-3-
nitrobenzotrifluoride (1.5 M, 1.0 equiv). Stock solutions A
(0.6 mL/min) and B (1.2 mL/min) were pumped from their
respective reservoirs and combined at a PEEK T-piece. The
combined flow was then combined at a second PEEK T-piece
with solution C (1.2 mL/min) and the flow directed into the
Coflore ACR (spring inserts). The ACR was agitated at 8 Hz
and heated at 65 °C. The flow stream was quenched by mixing
with a solution of hydrochloric acid (2 M) at a flow rate of
6 mL/min using a inline static mixing element (Esska [15]). The
biphasic mixture was passed into a collection vessel. The input
lines for two Knauer K120 HPLC pumps were positioned to
draw independently the aqueous and organic phases. The
organic layer was collected and dried (Na2SO4) and the solvent
evaporated to yield the title compound. The product was isolat-
ed in 93–97% yield.
1H NMR (400 MHz, chloroform-d) δ 8.51 (dt, J = 2.0, 0.6 Hz,
1H), 8.12–7.86 (m, 2H), 5.79 (s, 1H), 4.35 (q, J = 7.2 Hz, 2H),
1.37 (t, J = 7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 162.8
(C), 147.6 (C), 133.3 (q, J = 35 Hz, C), 132.4 (CH), 131.0 (q, J
= 4 Hz, CH), 128.9 (C), 123.7 (q, J = 4 Hz, CH), 122.2 (q, J =
273 Hz, C), 113.8 (C), 64.4 (CH2), 41.2 (CH), 13.9 (CH3);
19F NMR (376 MHz, CDCl3) δ −63.2; IR (neat) ν/cm−1: 3092
(w), 2925 (w), 1732 (m), 1537 (m), 1502 (m), 1357 (m), 1324
(s), 1257 (s), 1182 (s), 1138 (s), 1090 (s), 1012 (m), 866 (m),
825 (m), 698 (m); LC–MS (TOF+) 302.1 (M + H); HRMS (ESI)
m/z: calcd for C12H8N2O4F3, 301.0436; found, 301.0452 (Δ =
5.3 ppm); melting range: 60.5–61.6 °C; X-ray crystal data:
CCDC 1572810.
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Ethyl 6-(trifluoromethyl)-1H-indole-3-carboxylate (12) [23]:
A 0.2 M solution of compound 11 in a 1:1 mixture of EtOAc/
EtOH with 10 mol % AcOH was passed through a ThalesNano
H-cube at 1.3 mL/min containing a 10 mol % Pd/C heated at
50 °C and pressurised at 15 bar. The solvent was removed under
reduced pressure and the residue triturated with 9:1 hexane/
Et2O. The product was isolated in 93% yield. 1H NMR
(400 MHz, DMSO-d6) δ 12.33 (s, 1H), 8.31 (d, J = 3.0 Hz, 1H),
8.18 (dd, J = 8.5, 0.9 Hz, 1H), 7.83 (dt, J = 1.7, 0.9 Hz, 1H),
7.49 (dd, J = 8.5, 1.7 Hz, 1H), 4.31 (q, J = 7.1 Hz, 2H), 1.34 (t,
J = 7.1 Hz, 3H); 13C NMR (101 MHz, DMSO-d6) δ 164.4 (C),
135.8 (d, J = 3 Hz, CH), 128.7 (C), 125.4 (q, J = 273 Hz, C),
123.3 (q, J = 34 Hz, C), 121.75 (CH), 118.0 (q, J = 4 Hz, CH),
117.6 (C), 110.3 (q, J = 4 Hz, CH), 107.5 (C), 59.8 (CH2), 14.9
(CH3); 19F NMR (376 MHz, DMSO-d6) δ −59.3; IR (neat)
ν/cm−1: 3196 (m), 1667 (s), 1514 (m), 1440 (m), 1328 (s), 1228
(s), 1191 (m), 1160 (s), 1117 (s), 1055 (s), 826 (m), 745 (m),
674 (m), 615 (m), 524 (m); LC–MS (TOF+) 258.1 (M + H);
HRMS (ESI) m/z: calcd for C12H11NO2F3, 258.0742; found,
258.0753 (Δ = 4.3 ppm); melting range: 197.3–200.0 °C; X-ray
crystal data: CCDC 1572811.
Ethyl 2-amino-6-(trifluoromethyl)-1H-indole-3-carboxylate
(14) [45]:
1H NMR (400 MHz, DMSO-d6) δ 10.90 (br s, 1H), 7.68 (d, J =
8.0 Hz, 1H), 7.44 (s, 1H), 7.27 (d, J = 8.0 Hz, 1H), 7.00 (s, 2H),
4.26 (q, J = 7.2 Hz, 2H), 1.33 (t, J = 7.2 Hz, 3H); 13C NMR
(101 MHz, DMSO-d6) δ 165.9 (C), 155.3 (C), 132.5 (C), 130.5
(C), 126.0 (CF3, q, J = 271 Hz), 119.8 (C), 118.1 (CH, q, J = 31
Hz), 117.6 (CH, q, J = 4 Hz), 106.9 (CH, q, J = 4 Hz), 84.5 (C),
58.8 (CH2), 15.1 (CH3); 19F NMR (376 MHz, DMSO-d6) δ
−58.6; IR (neat) ν/cm−1: 3496 (m), 3344 (m), 1645 (m), 1619
(s), 1555 (m), 1506 (s), 1379 (m), 1325 (s), 1230 (m), 1152 (s),
1099 (s), 1070 (s), 1052 (s), 856 (m), 812 (s), 671 (m), 530 (m);
LC–MS (TOF+) 273.1 (M + H); HRMS (ESI) m/z: calcd for
C12H12N2O2F3, 273.0851; found, 273.0860 (Δ = 3.3 ppm);
melting range: >140 °C (decomposition); X-ray crystal data:
CCDC 1572812.
Ethyl 2-amino-1-hydroxy-6-(trifluoromethyl)-1H-indole-3-
carboxylate (15) [25]:
1H NMR (400 MHz, DMSO-d6) δ 11.55 (br s, 1H), 7.75 (d, J =
8.2 Hz, 1H), 7.36 (s, 1H), 7.33 (d, J = 8.2 Hz, 1H), 4.26 (q, J =
7.2 Hz, 2H), 1.33 (t, J = 7.2 Hz, 3H); 13C NMR (101 MHz,
DMSO-d6) δ 165.3 (C), 151.9 (C), 131.5 (C), 125.8 (CF3, q, J =
272 Hz), 125.7 (C), 120.0 (C, q, J = 32 Hz), 118.4 (CH), 118.1
(CH, q, J = 2 Hz), 103.7 (CH, q, J = 4 Hz), 80.4 (C), 58.9
(CH2), 15.2 (CH3); 19F NMR (376 MHz, DMSO-d6) δ −58.7;
IR (neat) ν/cm−1: 3266 (br), 3113 (br), 2981 (m), 1748 (s), 1696
(s), 1632 (m), 1441 (s), 1323 (s), 1254 (m), 1223 (m), 1172 (s),
1120 (s), 1060 (s), 879 (m), 824 (m), 668 (m); LC–MS (TOF+)
289.1 (M + H); HRMS (ESI) m/z: calcd for C12H12N2O3F3,
289.0800; found, 289.0805 (Δ = 1.7 ppm); melting range: de-
composition >145 °C.
6-(Trifluoromethyl)-1H-indole-3-carbohydrazide (13):
Two stock solutions in THF were prepared. Solution A:
hydrazine (1.00 M, 1.05 equiv) and solution B containing com-
pound 11 (0.95 M, 1.0 equiv). The two stock solutions were
pumped (0.65 mL/min each channel) from their respective
reservoirs to combine at a PEEK T-piece and were then directed
through a FEP flow coil (52 mL maintained at 100 °C using a
Polar Bear Plus reactor – Cambridge Reactor Design, residence
time 40 min). A 100 psi inline back pressure regulator was posi-
tioned prior to the exit. Collection of the reactor output allowed
isolation of the title compound in 81% isolated yield following
column silica chromatography (DCM/MeOH 9:1). 1H NMR
(400 MHz, DMSO-d6) δ 11.42 (br. s, 1H), 9.33 (s, 1H), 8.33 (d,
J = 8.4 Hz, 1H), 8.19 (s, 1H), 7.89–7.70 (m, 1H), 7.41 (dd, J =
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8.4, 1.7 Hz, 1H), 2.95 (br. s, 2 H); 13C NMR (101 MHz,
DMSO-d6) δ 164.9 (C), 135.3 (C), 130.5 (CH), 129.2 (C), 125.6
(q, J = 272 Hz, C), 122.8 (q, J = 31 Hz, C), 122.2 (CH), 117.0
(q, J = 4 Hz, CH), 109.8 (C), 109.8 (q, J = 4 Hz, CH); 19F NMR
(376 MHz, DMSO-d6) δ −59.0; IR (neat) ν/cm−1: 2900–3300
(broad), 3116 (m), 1615 (m), 1519 (m), 1376 (m), 1331 (s),
1238 (m), 1142 (m), 1096 (s), 1049 (s), 960 (m), 916 (m), 866
(s), 816 (s), 662 (s); LC–MS (TOF+) 244.1 (M + H); HRMS
(ESI) m/z: calcd for C10H9N3OF3, 244.0698; found, 244.0700
(Δ = 0.8 ppm); melting range: >220 °C (decomposition).
5-(6-(Trifluoromethyl)-1H-indol-3-yl)-1,3,4-oxadiazol-
2(3H)-one (8):
Stage 1: Two stock solutions in THF were prepared. Solution
A: hydrazine (1.00 M, 1.05 equiv) and solution B containing
compound 11 (0.95 M, 1.0 equiv). The two stock solutions were
pumped (0.65 mL/min each channel) from their respective
reservoirs to combine at a PEEK T-piece and were then directed
through a FEP flow coil (52 mL maintained at 100 °C using a
Polar Bear Plus reactor – Cambridge Reactor Design, residence
time 40 min). A 100 psi inline back pressure regulator was
added to control the system pressure.
Stage 2 (CDI): The reactor stream was further combined with a
input of CDI (1.1 M, 1.1 equiv) in THF (0.65 mL/min). The
unifided flow was directed through a second FEP flow coil
(52 mL heated at 75 °C using a Polar Bear Plus reactor –
Cambridge Reactor Design, residence time 26.7 min). A 75 psi
inline back pressure regulator was positioned at the exit of the
coil reactor to control the system pressure. A scavenging
cartridge of QP-SA (65 g, 3.4 mmol/g loading) was placed in
the flow path of the exiting solution. The reactor output was
collected and the solvent was evaporated under reduced pres-
sure allowing isolation of title compound 8 in 82% yield
following recrystalisation from DCM.
Alternative stage 2 (triphosgene): The reactor stream was
further combined with a input of triphosgene (0.8 M, 0.4 equiv)
in THF (0.325 mL/min). The unified flow was directed through
a second FEP flow coil (52 mL heated at 55 °C using a Polar
Bear Plus reactor – Cambridge Reactor Design, residence time
32 min). A 75 psi inline back pressure regulator was positioned
at the exit of the coil reactor to control the system pressure. A
scavenging cartridge of QP-DMA (70 g, 2.4 mmol/g loading)
was placed in the flow path of the exiting solution. The reactor
output was collected and the solvent was evaporated under
reduced pressure and enabling isolation of the title compound 8
in 91% yield as an off white solid.
1H NMR (400 MHz, DMSO-d6) δ 12.35 (br. s, 1H), 12.29 (br.
s, 1H), 8.23 (d, J = 1.4 Hz, 1H), 8.09 (d, J = 8.4 Hz, 1H), 7.85
(m, 1H), 7.50 (dd, J = 8.4, 1.4 Hz, 1H); 13C NMR (101 MHz,
DMSO-d6) δ 154.6 (C), 152.4 (C), 135.8 (C), 131.0 (CH), 126.8
(C), 125.3 (C, q, J = 272 Hz), 123.7 (C, q, J = 30 Hz), 121.4
(CH), 117.7 (CH, q, J = 4 Hz), 110.2 (CH, q, J = 5 Hz), 100.9
(C); 19F NMR (376 MHz, DMSO-d6) δ −59.3; IR (neat)
ν/cm−1: 3344 (br), 2820 (br), 1750 (s), 1628 (s), 1507 (m), 1455
(m), 1332 (s), 1224 (m), 1160 (m), 1100 (s), 1052 (s), 977 (m),
915 (m), 920 (m), 751 (m), 738 (s), 619 (s);. LC–MS (TOF+)
270.3 (M + H); HRMS (ESI) m/z: calcd for C11H7N3O2F3,
270.0490; found, 270.0497 (Δ = 2.6 ppm); melting range: de-
composition >220 °C; X-ray crystal data: CCDC 1572809.
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